Anne-Christine Januel named new ESMINT president

Interventional neuroradiologist Anne-Christine Januel (Toulouse University Hospital, Toulouse, France) has been elected as the new president of the European Society of Minimally Invasive Neurological Therapy...

Microvention officially rebrands to Terumo Neuro, reflecting “expanded focus and strategic growth”

Microvention, a wholly owned subsidiary of Terumo Corporation, has today announced its official rebranding to Terumo Neuro, effective immediately. This name change signifies a new...

Oxford Heartbeat completes patient recruitment in trial evaluating PreSize Neurovascular software

Oxford Heartbeat has today announced that the clinical impact trial of its artificial intelligence (AI)-powered PreSize Neurovascular software has successfully completed patient recruitment. A company press release...

Tiny ‘magnetic robot armies’ could be used to treat aneurysmal brain bleeds

Researchers have created nanoscale robots that could be used to manage bleeds in the brain caused by aneurysms, potentially enabling a more precise and...

Philips and WSO publish policy paper calling for “revolution in stroke care”

Royal Philips and the World Stroke Organization (WSO) have published a joint policy paper calling for a “revolution in stroke care” to make a real difference to the lives...

Remedy announces Phase 3 CHARM trial data indicating Cirara’s potential in large hemispheric infarction

Remedy Pharmaceuticals recently announced promising new data from the Phase 3 CHARM clinical trial of Cirara (intravenous glyburide) in patients with large hemispheric infarction (LHI)—a...

RapidAI and Alaska Stroke Coalition partner to overcome distance and other treatment barriers

RapidAI and the Alaska Stroke Coalition (ASC) have announced their partnership on the ‘Rapid AK’ project—a three-year initiative focused on advancing health equity for...

ESC 2024: Mass AF screening via ECG plus heart failure biomarker does not prevent...

Mass screening for atrial fibrillation (AF) using electrocardiography (ECG) together with a heart failure biomarker does not prevent ischaemic stroke or systemic in older...

HBA Support announces new patient-centred projects ahead of transition to registered charity status

Hereditary Brain Aneurysm (HBA) Support—a not-for-profit organisation providing information and support for individuals and families affected by hereditary brain aneurysms—has announced the upcoming launch...

Evasc announces treatment milestone alongside Eclips data presentation at ESMINT 2024

Evasc Neurovascular recently announced a “landmark achievement” during the 2024 European Society of Minimally Invasive Neurological Therapy (ESMINT) congress (4–6 September, Marseille, France), reporting...

SVS Vascular Quality Initiative launches Carotid Care Quality Champion programme

The Society for Vascular Surgery Vascular Quality Initiative (SVS VQI) clinical registry has announced the Carotid Care Quality Champion recognition programme. The programme honours healthcare...

Rapid completes interim safety analysis of DISTALS study evaluating Tigertriever 13 device

Rapid Medical has announced completion of the interim safety analysis from the multicentre, pivotal DISTALS study, reporting no safety concerns in medium vessel occlusions...

Younger brain aneurysm patients at heightened risk of developing mental health conditions

Among brain aneurysm patients, the risk of developing a mental health condition has been found to be higher as compared to among peers without...

Clearmind Biomedical announces US FDA clearance and initial case with Neuroblade system

Clearmind Biomedical has received US Food and Drug Administration (FDA) 510(k) clearance for its Neuroblade system—a novel neuroendoscopy system that enables minimally invasive procedures...

EShunt system receives US FDA Breakthrough Device designation for hydrocephalus treatment

Cerevasc has announced it has received Breakthrough Device designation from the US Food and Drug Administration (FDA) for its eShunt system, which is intended...

AtriClip LAA device receives expanded indication

AtriCure has received an expanded indication for the AtriClip left atrial appendage (LAA) exclusion system in CE-marked countries in Europe. The product is now indicated...